aldosterone has been researched along with Heart Diseases in 84 studies
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Angiotensin II and aldosterone often collaborate in pathological situations to induce hypertrophy of cardiomyocytes, vascular inflammation, perivascular and interstitial fibrosis, and microvascular rarefaction." | 8.89 | Aldosterone mediates cardiac fibrosis in the setting of hypertension. ( Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL, 2013) |
| "Leptin is a newly described regulator of aldosterone synthesis that acts directly on adrenal glomerulosa cells to increase CYP11B2 expression and enhance aldosterone production via calcium-dependent mechanisms." | 5.42 | Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. ( Antonova, G; Belin de Chantemèle, EJ; Bollag, WB; Filosa, JA; Gomez-Sanchez, CE; Groenendyk, J; Huby, AC, 2015) |
| "Telmisartan was administered to renovascular hypertensive rats at either a high dose (5 mg per kg per day; high-T group) or a low dose (0." | 5.35 | Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats. ( Hongo, K; Kawai, M; Komukai, K; Mochizuki, S; Morimoto, S; Nagai, M; Seki, S; Taniguchi, I; Yoshimura, M, 2009) |
| "Primary aldosteronism (PA) is characterized by the onset of both cardiac and gluco-metabolic alterations." | 5.34 | Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. ( Agostinelli, L; Boscaro, M; Giacchetti, G; Mantero, F; Rilli, S; Ronconi, V; Turchi, F, 2007) |
| " Angiotensin II and aldosterone often collaborate in pathological situations to induce hypertrophy of cardiomyocytes, vascular inflammation, perivascular and interstitial fibrosis, and microvascular rarefaction." | 4.89 | Aldosterone mediates cardiac fibrosis in the setting of hypertension. ( Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL, 2013) |
| "Hypertension was induced by continuous angiotensin II (Ang II) infusion via osmotic mini-pumps over 4 weeks." | 3.77 | Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage. ( Cordasic, N; Daniel, C; Hartner, A; Heusinger-Ribeiro, J; Hilgers, KF; Klanke, B; Knier, B; Veelken, R, 2011) |
| "Primary aldosteronism is common and contributes to adverse cardiovascular, kidney, and metabolic outcomes." | 2.66 | MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. ( Hundemer, GL; Vaidya, A, 2020) |
| "Aldosterone is a mineralocorticoid hormone with various direct harmful effects on the myocardium, including increased reactive oxygen species (ROS) generation, which contributes significantly to cardiac mitochondrial dysfunction and cardiac aging." | 2.61 | Adrenal βarrestin1 targeting for tobacco-associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link. ( Lymperopoulos, A; Mitaishvili, E; Solesio, ME, 2019) |
| "Stroke is a severe and frequent complication of Fabry disease (FD), affecting both males and females." | 1.56 | Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis. ( Bonardo, P; Reisin, RC; Rozenfeld, P, 2020) |
| "Primary aldosteronism is characterized by excess aldosterone (ALDO) secretion independent of the renin-angiotensin system and accounts for approximately 10% of hypertension cases." | 1.46 | Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats. ( Ball, JP; Hall, ME; Kc, R; Marañon, RO; Reckelhoff, JF; Romero, DG; Syed, M; Yanes Cardozo, LL, 2017) |
| "Leptin is a newly described regulator of aldosterone synthesis that acts directly on adrenal glomerulosa cells to increase CYP11B2 expression and enhance aldosterone production via calcium-dependent mechanisms." | 1.42 | Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. ( Antonova, G; Belin de Chantemèle, EJ; Bollag, WB; Filosa, JA; Gomez-Sanchez, CE; Groenendyk, J; Huby, AC, 2015) |
| "Primary hyperaldosteronism is the most common cause of secondary hypertension." | 1.39 | Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk. ( Abad-Cardiel, M; Alvarez-Álvarez, B; Fernández, C; Fernández-Cruz, A; Luque-Fernandez, L; Martell-Claros, N, 2013) |
| "Primary aldosteronism (PA) is sometimes associated with the autonomous secretion of cortisol." | 1.37 | Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. ( Hashimoto, K; Monden, T; Mori, M; Nakajima, Y; Okada, S; Ozawa, A; Satoh, T; Shibusawa, N; Taguchi, R; Yamada, M, 2011) |
| "Both fibrinogen and PAI-1 were independent predictors of the presence of organ damage and their inclusion in a multivariate model eliminated PRA and aldosterone as independent predictors." | 1.35 | Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. ( Casanova-Borca, A; Catena, C; Chiuch, A; Colussi, G; Di Fabio, A; Nadalini, E; Novello, M; Sechi, LA; Uzzau, A, 2008) |
| "Telmisartan was administered to renovascular hypertensive rats at either a high dose (5 mg per kg per day; high-T group) or a low dose (0." | 1.35 | Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats. ( Hongo, K; Kawai, M; Komukai, K; Mochizuki, S; Morimoto, S; Nagai, M; Seki, S; Taniguchi, I; Yoshimura, M, 2009) |
| "Primary aldosteronism (PA) is characterized by the onset of both cardiac and gluco-metabolic alterations." | 1.34 | Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. ( Agostinelli, L; Boscaro, M; Giacchetti, G; Mantero, F; Rilli, S; Ronconi, V; Turchi, F, 2007) |
| "Aldosterone plays a key role in the pathogenesis of Ang II-induced organ damage." | 1.33 | Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. ( Al-Saadi, N; Dechend, R; Fiebeler, A; Hilfenhaus, G; Jeng, AY; Luft, FC; Maser-Gluth, C; Meiners, S; Muller, DN; Nussberger, J; Rong, S; Shagdarsuren, E; Webb, RL; Wellner, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (39.29) | 18.7374 |
| 1990's | 3 (3.57) | 18.2507 |
| 2000's | 18 (21.43) | 29.6817 |
| 2010's | 25 (29.76) | 24.3611 |
| 2020's | 5 (5.95) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y | 3 |
| Xian, Y | 3 |
| Gao, X | 3 |
| Qiang, P | 3 |
| Hao, J | 3 |
| Yang, F | 3 |
| Shimosawa, T | 3 |
| Chang, Y | 3 |
| Xu, Q | 3 |
| Williams, GH | 2 |
| Chapman, K | 1 |
| Hundemer, GL | 1 |
| Vaidya, A | 1 |
| Hill, MA | 1 |
| Jaisser, F | 2 |
| Sowers, JR | 1 |
| Reisin, RC | 1 |
| Rozenfeld, P | 1 |
| Bonardo, P | 1 |
| Ball, JP | 1 |
| Syed, M | 1 |
| Marañon, RO | 1 |
| Hall, ME | 1 |
| Kc, R | 1 |
| Reckelhoff, JF | 1 |
| Yanes Cardozo, LL | 1 |
| Romero, DG | 1 |
| Zhang, YD | 1 |
| Ding, XJ | 1 |
| Dai, HY | 1 |
| Peng, WS | 1 |
| Guo, NF | 1 |
| Zhang, Y | 2 |
| Zhou, QL | 1 |
| Chen, XL | 1 |
| Kesireddy, V | 1 |
| Tan, Y | 1 |
| Kline, D | 1 |
| Brock, G | 1 |
| Odei, JB | 1 |
| Kluwe, B | 1 |
| Effoe, VS | 1 |
| Echouffo Tcheugui, JB | 1 |
| Kalyani, RR | 1 |
| Sims, M | 1 |
| Taylor, HA | 1 |
| Mongraw-Chaffin, M | 1 |
| Akhabue, E | 1 |
| Joseph, JJ | 1 |
| Solesio, ME | 1 |
| Mitaishvili, E | 1 |
| Lymperopoulos, A | 1 |
| Ocello, A | 1 |
| La Rosa, S | 1 |
| Fiorini, F | 1 |
| Randone, S | 1 |
| Maccarrone, R | 1 |
| Battaglia, G | 1 |
| Granata, A | 1 |
| Azibani, F | 1 |
| Fazal, L | 1 |
| Chatziantoniou, C | 1 |
| Samuel, JL | 1 |
| Delcayre, C | 1 |
| Hattori, T | 1 |
| Murase, T | 1 |
| Sugiura, Y | 1 |
| Nagasawa, K | 1 |
| Takahashi, K | 1 |
| Ohtake, M | 2 |
| Miyachi, M | 1 |
| Murohara, T | 1 |
| Nagata, K | 1 |
| Bauersachs, J | 1 |
| Toto, R | 1 |
| Huby, AC | 1 |
| Antonova, G | 1 |
| Groenendyk, J | 1 |
| Gomez-Sanchez, CE | 1 |
| Bollag, WB | 1 |
| Filosa, JA | 1 |
| Belin de Chantemèle, EJ | 1 |
| Peng, W | 1 |
| Ao, X | 1 |
| Dai, H | 1 |
| Yuan, L | 1 |
| Huang, X | 1 |
| Zhou, Q | 1 |
| Cannavo, A | 1 |
| Liccardo, D | 1 |
| Eguchi, A | 1 |
| Elliott, KJ | 1 |
| Traynham, CJ | 1 |
| Ibetti, J | 1 |
| Eguchi, S | 1 |
| Leosco, D | 1 |
| Ferrara, N | 1 |
| Rengo, G | 1 |
| Koch, WJ | 1 |
| Lother, A | 1 |
| Hein, L | 1 |
| Lasheen, NN | 1 |
| Mohamed, GF | 1 |
| Sechi, LA | 2 |
| Novello, M | 1 |
| Colussi, G | 2 |
| Di Fabio, A | 1 |
| Chiuch, A | 1 |
| Nadalini, E | 1 |
| Casanova-Borca, A | 1 |
| Uzzau, A | 1 |
| Catena, C | 2 |
| Wu, R | 1 |
| Zeng, Y | 1 |
| Kawai, M | 1 |
| Hongo, K | 1 |
| Komukai, K | 1 |
| Morimoto, S | 1 |
| Nagai, M | 1 |
| Seki, S | 1 |
| Taniguchi, I | 1 |
| Mochizuki, S | 1 |
| Yoshimura, M | 1 |
| Kubzansky, LD | 1 |
| Adler, GK | 2 |
| Cetrullo, S | 1 |
| Facchini, A | 1 |
| Stanic, I | 1 |
| Tantini, B | 1 |
| Pignatti, C | 1 |
| Caldarera, CM | 1 |
| Flamigni, F | 1 |
| López, B | 1 |
| González, A | 1 |
| Díez, J | 1 |
| Radović, M | 2 |
| Damjanović, S | 1 |
| Nale, D | 1 |
| Mićić, S | 1 |
| Vučović, D | 1 |
| Nakajima, Y | 1 |
| Yamada, M | 1 |
| Taguchi, R | 1 |
| Satoh, T | 1 |
| Hashimoto, K | 1 |
| Ozawa, A | 1 |
| Shibusawa, N | 1 |
| Okada, S | 1 |
| Monden, T | 1 |
| Mori, M | 1 |
| Knier, B | 1 |
| Cordasic, N | 1 |
| Klanke, B | 1 |
| Heusinger-Ribeiro, J | 1 |
| Daniel, C | 1 |
| Veelken, R | 1 |
| Hartner, A | 1 |
| Hilgers, KF | 1 |
| Marzano, L | 1 |
| Luther, JM | 1 |
| Luo, P | 1 |
| Wang, Z | 1 |
| Cohen, SE | 1 |
| Kim, HS | 1 |
| Fogo, AB | 1 |
| Brown, NJ | 1 |
| Brem, AS | 1 |
| Nagase, M | 1 |
| Abad-Cardiel, M | 1 |
| Alvarez-Álvarez, B | 1 |
| Luque-Fernandez, L | 1 |
| Fernández, C | 1 |
| Fernández-Cruz, A | 1 |
| Martell-Claros, N | 1 |
| Firsov, D | 1 |
| Muller, OG | 1 |
| White, PC | 1 |
| Pearce, D | 1 |
| Bhargava, A | 1 |
| Cole, TJ | 1 |
| Fiebeler, A | 2 |
| Haller, H | 1 |
| Hostetter, TH | 1 |
| Ibrahim, HN | 1 |
| BUCHBORN, E | 3 |
| KOCZOREK, KR | 3 |
| KOHLER, M | 2 |
| WOLFF, HP | 3 |
| DI PERRI, T | 2 |
| GUIDERI, R | 2 |
| RAVENNI, G | 2 |
| MONCIATTI, C | 1 |
| BIANCHI, V | 2 |
| SANDERS, LL | 1 |
| MELBY, JC | 1 |
| HANADA, M | 1 |
| SAMBHI, MP | 1 |
| VENNING, EH | 1 |
| BECK, JC | 1 |
| HALL, CE | 1 |
| HALL, O | 1 |
| Van Den Meiracker, AH | 1 |
| Huizenga, AT | 1 |
| Boomsma, F | 1 |
| Mitka, M | 1 |
| Nussberger, J | 1 |
| Shagdarsuren, E | 1 |
| Rong, S | 1 |
| Hilfenhaus, G | 1 |
| Al-Saadi, N | 1 |
| Dechend, R | 1 |
| Wellner, M | 1 |
| Meiners, S | 1 |
| Maser-Gluth, C | 1 |
| Jeng, AY | 1 |
| Webb, RL | 1 |
| Luft, FC | 1 |
| Muller, DN | 1 |
| Sun, Y | 1 |
| Weber, KT | 1 |
| Lahera, V | 1 |
| Cachofeiro, V | 1 |
| Balfagon, G | 1 |
| Rodicio, JL | 1 |
| Giacchetti, G | 1 |
| Ronconi, V | 1 |
| Turchi, F | 1 |
| Agostinelli, L | 1 |
| Mantero, F | 1 |
| Rilli, S | 1 |
| Boscaro, M | 1 |
| Kagiyama, S | 1 |
| Matsumura, K | 1 |
| Fukuhara, M | 1 |
| Sakagami, K | 1 |
| Fujii, K | 1 |
| Iida, M | 1 |
| Funder, JW | 1 |
| Funck, RC | 1 |
| Wilke, A | 1 |
| Rupp, H | 1 |
| Brilla, CG | 1 |
| Lijnen, P | 1 |
| Petrov, V | 1 |
| Stowasser, M | 1 |
| Martinez, DV | 1 |
| Rocha, R | 1 |
| Matsumura, M | 1 |
| Oestreicher, E | 1 |
| Ochoa-Maya, M | 1 |
| Roubsanthisuk, W | 1 |
| Knowlen, GG | 1 |
| Kittleson, MD | 1 |
| Nachreiner, RF | 1 |
| Eyster, GE | 1 |
| Zweifler, AJ | 1 |
| Esler, M | 1 |
| Shushliapin, OI | 1 |
| Stimpel, M | 1 |
| Kaufmann, W | 2 |
| Wambach, G | 1 |
| Grimaldi, A | 1 |
| Pruszczynski, W | 1 |
| Thervet, F | 1 |
| Ardaillou, R | 1 |
| Regan, TJ | 1 |
| Pathan, A | 1 |
| Weisse, AB | 1 |
| Eaddy, C | 1 |
| Torres, R | 1 |
| Jayle, MF | 1 |
| Legrand, JC | 1 |
| Pasqualini, JR | 1 |
| Cruz, IA | 1 |
| Dillard, MG | 1 |
| Hosten, AO | 1 |
| Dioguardi, N | 1 |
| Iimura, O | 2 |
| Miyahara, M | 1 |
| Kukuiri, T | 1 |
| Abe, H | 1 |
| Ueda, T | 1 |
| Weil, MH | 1 |
| Shubin, H | 1 |
| Friedberg, CK | 1 |
| Yoshida, H | 1 |
| Mizukoshi, H | 1 |
| Araki, Y | 1 |
| Oelert, H | 1 |
| Jick, H | 1 |
| Müller, C | 2 |
| Lutz, H | 2 |
| Schmitz, W | 2 |
| Reiss, F | 2 |
| Ito, T | 1 |
| Nakamura, K | 1 |
| Kinouchi, T | 1 |
| Kurosawa, T | 1 |
| Oshima, M | 1 |
| Manta, I | 1 |
| Hodîrnău, A | 1 |
| Proinov, I | 1 |
| Băltescu, V | 1 |
| Schneider, E | 1 |
| Barbi, G | 1 |
| Giocoli, G | 1 |
| Cavina, G | 1 |
| Sardini, D | 1 |
| Vinogradov, AV | 1 |
| Sycheva, IM | 1 |
| Kiseleva, ZM | 1 |
| Schaison, G | 1 |
| Kinoshita, M | 1 |
| Siegenthaler, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
27 reviews available for aldosterone and Heart Diseases
| Article | Year |
|---|---|
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Endocrine System Diseases; Heart Diseases; Humans; Hyperaldosteronism; K | 2020 |
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness.
Topics: Aldosterone; Coronary Circulation; Coronary Vessels; Endothelial Cells; Epithelial Sodium Channels; | 2022 |
Adrenal βarrestin1 targeting for tobacco-associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link.
Topics: Adrenal Glands; Aldosterone; beta-Arrestin 1; Cotinine; Heart Diseases; Humans; Molecular Targeted T | 2019 |
[Antifibrotic renal role of mineralcorticoid receptor antagonists].
Topics: Aldosterone; Body Fluids; Cardiovascular Diseases; Clinical Trials as Topic; Cytokines; Diabetic Nep | 2019 |
Aldosterone mediates cardiac fibrosis in the setting of hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cytochrome P-450 CYP11B2; Fibrosis; Heart Diseases; Humans; Hy | 2013 |
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Animals; Blood Pressure; Clinical Trials as Topi | 2015 |
Vascular Mineralocorticoid Receptors: Linking Risk Factors, Hypertension, and Heart Disease.
Topics: Aldosterone; Blood Vessels; Heart Diseases; Humans; Hypertension; Receptors, Mineralocorticoid; Risk | 2016 |
Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.
Topics: Aldosterone; Animals; Brain; Heart Diseases; Humans; Models, Biological; Stress, Psychological | 2010 |
Aldosterone and the heart: from basic research to clinical evidence.
Topics: Aldosterone; Animals; Heart; Heart Diseases; Humans; Hyperaldosteronism | 2012 |
[Mineralocorticoid receptor: an update].
Topics: Aldosterone; Animals; Heart Diseases; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonist | 2012 |
Aldosterone action in the heart.
Topics: Aldosterone; Animals; Cardiovascular Physiological Phenomena; Heart; Heart Diseases; Humans | 2003 |
Aldosterone: direct effects on and production by the heart.
Topics: Aldosterone; Animals; Cardiovascular Physiological Phenomena; Cytochrome P-450 CYP11B2; Electrophysi | 2003 |
Aldosterone: its receptor, target genes, and actions.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Brain; Chromatin; Epithelium; Gen | 2003 |
Participation of the mineralocorticoid receptor in cardiac and vascular remodeling.
Topics: Aldosterone; Animals; Heart Diseases; Humans; Kidney; Mice; Mineralocorticoid Receptor Antagonists; | 2003 |
Aldosterone in chronic kidney and cardiac disease.
Topics: Aldosterone; Chronic Disease; Heart Diseases; Humans; Kidney Diseases | 2003 |
[Profibrotic effects of aldosterone].
Topics: Aldosterone; Animals; Fibrosis; Heart Diseases; Humans; Mineralocorticoid Receptor Antagonists; Myoc | 2004 |
Aldosterone and its blockade: a cardiovascular and renal perspective.
Topics: Aldosterone; Cardiovascular Physiological Phenomena; Heart Diseases; Humans; Kidney; Kidney Diseases | 2006 |
Mineralocorticoid receptors and hypertension.
Topics: Aldosterone; Animals; Epithelium; Heart Diseases; Hypertension; Rats; Receptors, Glucocorticoid; Rec | 1995 |
Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
Topics: Adult; Aldosterone; Angiotensin II; Animals; Cells, Cultured; Collagen; Collagenases; Heart; Heart D | 1997 |
Induction of cardiac fibrosis by aldosterone.
Topics: Aldosterone; Animals; Collagen; Fibroblasts; Fibrosis; Heart; Heart Diseases; Humans; Mineralocortic | 2000 |
New perspectives on the role of aldosterone excess in cardiovascular disease.
Topics: Aldosterone; Animals; Heart Diseases; Humans; Hyperaldosteronism | 2001 |
[Recent data on the physiopathologic metabolism of aldosterone].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Aorta; Edema; Female; Heart Disea | 1967 |
[Heart diseases, hypertension and hormonal anomaly--with special reference to aldosterone and catecholamine].
Topics: Aldosterone; Catecholamines; Heart Diseases; Humans; Hypertension; Hyperthyroidism | 1967 |
Shock following acute myocardial infarction. Current understanding of hemodynamic mechanisms.
Topics: Acidosis; Aldosterone; Animals; Arrhythmias, Cardiac; Arteries; Blood Flow Velocity; Blood Pressure; | 1968 |
Edema and pulmonary edema: pathologic physiology and differential diagnosis.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Edema; Extracellular Space; Female; Heart Dise | 1971 |
[The third factor].
Topics: Aldosterone; Animals; Biological Assay; Dogs; Extracorporeal Circulation; Female; Glomerular Filtrat | 1971 |
[Aldosterone and aldosterone antagonists in surgery].
Topics: Adult; Aldosterone; Blood Volume; Brain Edema; Cardiac Surgical Procedures; Child; Digitalis Glycosi | 1971 |
1 trial available for aldosterone and Heart Diseases
| Article | Year |
|---|---|
Modulation of aldosterone release by epidural analgesia impacts brain natriuretic peptide: a link to stress cardiomyopathy? Pilot study.
Topics: Aldosterone; Analgesia, Epidural; Anesthesia, General; Heart Diseases; Humans; Male; Middle Aged; Na | 2011 |
56 other studies available for aldosterone and Heart Diseases
| Article | Year |
|---|---|
Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.
Topics: Aldosterone; Animals; Cardio-Renal Syndrome; Eplerenone; Fibrosis; Heart Diseases; Macrophages; Myof | 2022 |
Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.
Topics: Aldosterone; Animals; Cardio-Renal Syndrome; Eplerenone; Fibrosis; Heart Diseases; Macrophages; Myof | 2022 |
Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.
Topics: Aldosterone; Animals; Cardio-Renal Syndrome; Eplerenone; Fibrosis; Heart Diseases; Macrophages; Myof | 2022 |
Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.
Topics: Aldosterone; Animals; Cardio-Renal Syndrome; Eplerenone; Fibrosis; Heart Diseases; Macrophages; Myof | 2022 |
Aldosterone: The Missing Cardiorenal Link.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Heart Diseases; Humans; Kidney Diseases; Mine | 2019 |
Cardiac gluco- and mineralocorticoid receptors: From development to pathology.
Topics: Aldosterone; Heart Diseases; Humans; Hydrocortisone; Receptors, Glucocorticoid; Receptors, Mineraloc | 2021 |
Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.
Topics: Aldosterone; Angiotensin-Converting Enzyme 2; COVID-19; Endothelium, Vascular; Fabry Disease; Female | 2020 |
Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.
Topics: Aldosterone; Animals; Gene Expression Regulation; Heart; Heart Diseases; Hyperaldosteronism; Hyperte | 2017 |
SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy.
Topics: Aldosterone; Animals; Autophagy; Cytokines; Fibrosis; Glycogen Synthase Kinase 3 beta; Heart Disease | 2018 |
The Association of Life's Simple 7 with Aldosterone among African Americans in the Jackson Heart Study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Black or African American; Blood Glucose; Female; Heart | 2019 |
Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Echocardiography; Endoth | 2014 |
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis.
Topics: Adipocytes; Adrenal Cortex; Aldosterone; Animals; Cell Line, Tumor; Cells, Cultured; Endothelium, Va | 2015 |
TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury.
Topics: Acute Kidney Injury; Aldosterone; Animals; Cytokines; Heart Diseases; Hemodynamics; Inflammation; Ma | 2015 |
Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases.
Topics: Aldosterone; Animals; Arrestins; beta-Arrestins; Cell Culture Techniques; Cell Movement; G-Protein-C | 2016 |
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Topics: Acidosis; Aldosterone; Ammonium Chloride; Animals; Chronic Disease; Echocardiography; Electrocardiog | 2016 |
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Topics: Adult; Aldosterone; Algorithms; Analysis of Variance; Biomarkers; Cerebrovascular Disorders; Cross-S | 2008 |
Does angiotensin II-aldosterone have a role in radiation-induced heart disease?
Topics: Aldosterone; Angiotensin II; Animals; Dose-Response Relationship, Radiation; Heart Diseases; Myocard | 2009 |
Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Vess | 2009 |
Difluoromethylornithine inhibits hypertrophic, pro-fibrotic and pro-apoptotic actions of aldosterone in cardiac cells.
Topics: Aldosterone; Animals; Apoptosis; Biogenic Polyamines; Cells, Cultured; Eflornithine; Fibrosis; Gene | 2010 |
Circulating biomarkers of collagen metabolism in cardiac diseases.
Topics: Aldosterone; Biomarkers; Carrier Proteins; Collagen; Connective Tissue Growth Factor; Heart Diseases | 2010 |
Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Circadian Rhythm; Cross-Sectional Studies; Female; Hear | 2011 |
Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Fibrinolysin; Fibrosis | 2011 |
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Topics: Aldosterone; Angiotensin II; Animals; Aorta; Biomarkers; Blood Pressure; Cytochrome P-450 CYP11B2; D | 2012 |
Targeting activated mineralocorticoid receptor: Occam's razor revisited.
Topics: Aldosterone; Angiotensin II; Animals; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor An | 2012 |
Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk.
Topics: Aged; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female; Heart Diseases; | 2013 |
[Aldosterone activity and sodium retention in heart disease and its pathophysiologic significance].
Topics: Aldosterone; Heart Diseases; Humans; Hypernatremia; Ions; Sodium; Sodium, Dietary | 1956 |
[Aldosterone activity and sodium retention in heart disease and its pathophysiologic significance].
Topics: Aldosterone; Heart Diseases; Humans; Hypernatremia; Ions; Sodium; Sodium, Dietary | 1956 |
[Aldosterone activity and sodium retention in heart disease and its pathophysiologic significance].
Topics: Aldosterone; Heart Diseases; Humans; Hypernatremia; Ions; Sodium; Sodium, Dietary | 1956 |
[Aldosterone activity and sodium retention in heart disease and its pathophysiologic significance].
Topics: Aldosterone; Heart Diseases; Humans; Hypernatremia; Ions; Sodium; Sodium, Dietary | 1956 |
Hyperaldosteronism in heart disease.
Topics: Aldosterone; Heart Diseases; Heart Failure; Humans; Hyperaldosteronism | 1957 |
[The pathogenesis of nyctohemeral variations in urinary aldosterone and in the elimination of water and sodium in heart disease patients].
Topics: Aldosterone; Biological Transport; Heart Diseases; Humans; Ions; Sodium; Sodium, Dietary; Water | 1958 |
[Nocturnal urination of cardiac patients; study of the pathogenesis as a function of aldosterone secretion].
Topics: Aldosterone; Heart Diseases; Humans; Posture; Urination | 1959 |
ALDOSTERONE AND THE EDEMA OF CONGESTIVE HEART FAILURE.
Topics: Aldosterone; Chromatography; Diuretics; Edema; Geriatrics; Heart Diseases; Heart Failure; Hypertensi | 1964 |
[ALDOSTERONE SECRETION RATE IN VARIOUS DISEASES].
Topics: Aldosterone; Cushing Syndrome; Diabetic Nephropathies; Heart Diseases; Humans; Hyperaldosteronism; H | 1963 |
ALDOSTERONE SECRETION RATE AND ELECTROLYTE BALANCE STUDIES ON THREE PATIENTS WITH HYPERTENSION. INFLUENCE OF GUANETHIDINE, HYDRALAZINE AND METHYCLOTHIAZIDE.
Topics: Aldosterone; Diet, Sodium-Restricted; Diuretics; Guanethidine; Heart Diseases; Humans; Hydralazine; | 1964 |
HYPERTENSION AND HYPERSALIMENTATION. I. ALDOSTERONE HYPERTENSION.
Topics: Adrenal Glands; Aldosterone; Arteritis; Diet; Heart Diseases; Hypertension; Kidney; Metabolism; Myoc | 1965 |
Scientists probe aldosterone's role in hypertension and heart disease.
Topics: Aldosterone; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Heart Diseases; Humans; | 2004 |
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Angiotensin II; Angiotensinogen; Animals; Animals, Genet | 2005 |
Animal models of cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; | 2005 |
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Blood Glucose | 2007 |
Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Ca | 2007 |
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
Topics: Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Eplerenone; H | 2002 |
Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; | 1983 |
Factors influencing the choice of antihypertensive agents.
Topics: Age Factors; Aldosterone; Cerebrovascular Disorders; Clonidine; Depression; Diabetes Complications; | 1976 |
[Change of certain humoral and hemodynamic factors in chronic circulatory insufficiency].
Topics: Aldosterone; Blood Circulation; Female; Heart Diseases; Hemodynamics; Humans; Male; Renin | 1975 |
A symposium: International update--the important role of aldosterone and aldosterone antagonism in cardiovascular medicine. Based on symposia held in Brussels, Belgium and Newport Beach, California.
Topics: Aldosterone; Heart Diseases; Humans; Hypertension; Mineralocorticoid Receptor Antagonists | 1990 |
[Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Catecholamines; Female; Heart Disease | 1988 |
Antidiuretic hormone response to volume depletion in diabetic patients with cardiac autonomic dysfunction.
Topics: Adult; Aldosterone; Autonomic Nervous System Diseases; Blood Pressure; Blood Volume; Diabetic Neurop | 1985 |
The contribution of arterial pressure to the cardiac dysfunction of chronic alcoholism.
Topics: Adult; Alcoholism; Aldosterone; Blood Pressure; Catecholamines; Echocardiography; Electrolytes; Hear | 1985 |
Selective hypoaldosteronism: a case report and review of literature.
Topics: Adrenal Insufficiency; Adult; Aldosterone; Diabetes Complications; Heart Diseases; Humans; Hyperkale | 1974 |
[Edema in the patient with heart disease].
Topics: Aldosterone; Blood Pressure; Edema; Glomerular Filtration Rate; Heart Diseases; Heart Failure; Human | 1973 |
Actual incidence of secondary hypertension.
Topics: Adult; Aldosterone; Biopsy; Blood Pressure; Catecholamines; Cushing Syndrome; Diagnosis, Differentia | 1973 |
The use of glucocorticoids for diuresis in patients with fluid retention not resulting from renal disease.
Topics: Aldosterone; Chlorothiazide; Diuresis; Edema; Glomerular Filtration Rate; Glucocorticoids; Heart Dis | 1966 |
[Electrolyte changes in heart surgery with autogenous blood dilution perfusions].
Topics: Adolescent; Adult; Aldosterone; Child; Erythrocytes; Extracorporeal Circulation; Heart Defects, Cong | 1968 |
The role of aldosterone in the pathogenesis of congestive heart failure.
Topics: Aldosterone; Animals; Dogs; Edema; Female; Heart Diseases; Heart Failure; Humans; Mannitol; Potassiu | 1967 |
[Research on arterial hypertension. Significance of aldosterone, catecholamines, amino acids and some electrolytes in compensated and decompensated cardiac lesions].
Topics: Adult; Aged; Aldosterone; Amino Acids; Catecholamines; Coronary Disease; Electrolytes; Female; Heart | 1970 |
[Clinical evaluation of a new method for the determination of urinary aldosterone].
Topics: Aldosterone; Chromatography, Thin Layer; Edema; Female; Heart Diseases; Humans; Hyperaldosteronism; | 1971 |
[The significance of aldosterone in the pathogenesis of edema in cardiac insufficiency].
Topics: Adult; Aged; Aldosterone; Edema; Female; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; P | 1967 |
[Physiopathology and treatment of hyponatremia (II)].
Topics: Adrenal Insufficiency; Aldosterone; Anesthesia; Diuretics; Heart Diseases; Humans; Hyperpituitarism; | 1968 |
[Electrolyte changes in heart surgery with autogenous blood dilution perfusions].
Topics: Adolescent; Adult; Aldosterone; Child; Erythrocytes; Extracorporeal Circulation; Heart Defects, Cong | 1968 |
Studies on cardiac output to blood volume, and renal circulation in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Arteriosclerosis; Blood Pressure; Blood Volume; Cardiac Output; Chronic Di | 1968 |
[Diuretic therapy of hydropic cardiac insufficiency].
Topics: Aldosterone; Diuretics; Edema; Heart Diseases; Humans; Sulfonamides; Sympatholytics | 1965 |